Zhonghua Chu

995 total citations
36 papers, 759 citations indexed

About

Zhonghua Chu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zhonghua Chu has authored 36 papers receiving a total of 759 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 15 papers in Oncology and 13 papers in Cancer Research. Recurrent topics in Zhonghua Chu's work include MicroRNA in disease regulation (7 papers), Protein Tyrosine Phosphatases (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Zhonghua Chu is often cited by papers focused on MicroRNA in disease regulation (7 papers), Protein Tyrosine Phosphatases (7 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Zhonghua Chu collaborates with scholars based in China, United States and Singapore. Zhonghua Chu's co-authors include Yujie Zeng, Heng Wu, Heyang Xu, Lai Wei, Lu Liu, Qiusheng Lan, Shuang Chen, Min Jun, Jie Wang and Lin Li and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Journal of Hematology & Oncology.

In The Last Decade

Zhonghua Chu

33 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhonghua Chu China 17 461 227 207 182 69 36 759
Yueshuo Li China 13 414 0.9× 199 0.9× 135 0.7× 151 0.8× 61 0.9× 19 695
Lingxiao Xu China 19 313 0.7× 177 0.8× 283 1.4× 82 0.5× 55 0.8× 49 843
Luoyan Ai China 12 397 0.9× 371 1.6× 220 1.1× 122 0.7× 119 1.7× 23 837
Weiming Zhao China 17 459 1.0× 136 0.6× 124 0.6× 152 0.8× 55 0.8× 43 761
Guobin Song China 14 318 0.7× 154 0.7× 265 1.3× 172 0.9× 136 2.0× 26 710
Panagiotis Tsapogas Switzerland 20 454 1.0× 162 0.7× 459 2.2× 77 0.4× 44 0.6× 34 1.3k
Tiffany A. Coon United States 19 743 1.6× 174 0.8× 242 1.2× 141 0.8× 151 2.2× 27 1.1k
Junfang Deng China 14 280 0.6× 200 0.9× 209 1.0× 146 0.8× 61 0.9× 21 648
Loredana Albonici Italy 14 191 0.4× 156 0.7× 188 0.9× 82 0.5× 76 1.1× 33 644
Huan Zhou China 15 382 0.8× 278 1.2× 156 0.8× 227 1.2× 112 1.6× 26 714

Countries citing papers authored by Zhonghua Chu

Since Specialization
Citations

This map shows the geographic impact of Zhonghua Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhonghua Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhonghua Chu more than expected).

Fields of papers citing papers by Zhonghua Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhonghua Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhonghua Chu. The network helps show where Zhonghua Chu may publish in the future.

Co-authorship network of co-authors of Zhonghua Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhonghua Chu. A scholar is included among the top collaborators of Zhonghua Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhonghua Chu. Zhonghua Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wu, Junchen, et al.. (2025). Penile metastasis from colon cancer with BRAFV600E mutation treated with BRAF/MEK-targeted therapy plus cetuximab: A case report. World Journal of Gastrointestinal Oncology. 17(3). 100152–100152. 1 indexed citations
2.
Lan, Qiusheng, Wentao Liu, Xinwen Hu, et al.. (2024). Granulocyte-like myeloid-derived suppressor cells: The culprits of neutrophil extracellular traps formation in the pre-metastatic niche. International Immunopharmacology. 143(Pt 3). 113500–113500. 1 indexed citations
3.
4.
He, Jiehua, Ziqiang Chu, Lai Wei, et al.. (2021). Circular RNA circHERC4 as a novel oncogenic driver to promote tumor metastasis via the miR-556-5p/CTBP2/E-cadherin axis in colorectal cancer. Journal of Hematology & Oncology. 14(1). 194–194. 53 indexed citations
5.
Xu, Heyang, Qiusheng Lan, Yong‐Liang Huang, et al.. (2021). The mechanisms of colorectal cancer cell mesenchymal-epithelial transition induced by hepatocyte exosome-derived miR-203a-3p. BMC Cancer. 21(1). 718–718. 22 indexed citations
6.
Yao, Qiulin, Meifang Tang, Zhonghua Chu, et al.. (2021). Potential of fecal microbiota for detection and postoperative surveillance of colorectal cancer. BMC Microbiology. 21(1). 156–156. 10 indexed citations
7.
8.
Li, Yong, Guoxin Li, Zhonghua Chu, et al.. (2018). Conversion chemotherapy with capecitabine and oxaliplatin for colorectal cancer with potentially resectable liver metastases. Journal of Cancer Research and Therapeutics. 14(4). 772–779. 3 indexed citations
9.
Lan, Qiusheng, Lai Wei, Yujie Zeng, et al.. (2017). CCL26 Participates in the PRL-3–Induced Promotion of Colorectal Cancer Invasion by Stimulating Tumor-Associated Macrophage Infiltration. Molecular Cancer Therapeutics. 17(1). 276–289. 53 indexed citations
10.
Wang, Wei, Xingyu Feng, Yu Zhang, et al.. (2017). Clinicopathological characteristics and prognostic factors of rectal neuroendocrine neoplasms. Zhonghua putong waike zazhi. 32(10). 828–831. 1 indexed citations
11.
Xu, Heyang, Yujie Zeng, Lu Liu, et al.. (2017). PRL-3 improves colorectal cancer cell proliferation and invasion through IL-8 mediated glycolysis metabolism. International Journal of Oncology. 51(4). 1271–1279. 30 indexed citations
12.
Chen, Shaojie, Yinting Chen, Linjuan Zeng, et al.. (2016). Bmi1 combines with oncogenic KRAS to induce malignant transformation of human pancreatic duct cells in vitro. Tumor Biology. 37(8). 11299–11309. 5 indexed citations
13.
Yan, Haiyan, Kaishun Hu, Wenjing Wu, et al.. (2016). Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer. PLoS ONE. 11(8). e0159954–e0159954. 26 indexed citations
14.
Liu, Lu, et al.. (2014). Laparoscopic Anterior Approach of Major Hepatectomy Combined With Colorectal Resection for Synchronous Colorectal Liver Metastases. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 24(6). e237–e240. 16 indexed citations
15.
Zeng, Yujie, Lai Wei, Lu Liu, et al.. (2014). Prognostic Significance of Neuroendocrine Differentiation in Colorectal Adenocarcinoma After Radical Operation: a Meta-analysis. Journal of Gastrointestinal Surgery. 18(5). 968–976. 16 indexed citations
16.
Zeng, Yujie, Lu Liu, Heng Wu, et al.. (2013). Clinicopathological Features and Prognosis of Gastroenteropancreatic Neuroendocrine Tumors: Analysis from a Single-institution. Asian Pacific Journal of Cancer Prevention. 14(10). 5775–5781. 18 indexed citations
17.
Jun, Min, et al.. (2012). Maturation induction of human peripheral blood mononuclear cell-derived dendritic cells. Experimental and Therapeutic Medicine. 4(1). 131–134. 23 indexed citations
18.
Liu, Lu, Lin Li, Min Jun, et al.. (2012). Butyrate interferes with the differentiation and function of human monocyte-derived dendritic cells. Cellular Immunology. 277(1-2). 66–73. 121 indexed citations
19.
Chu, Zhonghua, et al.. (2011). Proteomic analysis identifies translationally controlled tumor protein as a mediator of phosphatase of regenerating liver-3-promoted proliferation, migration and invasion in human colon cancer cells.. PubMed. 124(22). 3778–85. 11 indexed citations
20.
Jun, Min, et al.. (2004). [Study of embryonic stem cells induced to express hepatic cell functions in vitro in a pathologic niche containing cholestatic serum].. PubMed. 12(12). 726–9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yueshuo Li Breakdown of academic impact, for papers by Lingxiao Xu Breakdown of academic impact, for papers by Luoyan Ai Breakdown of academic impact, for papers by Weiming Zhao Breakdown of academic impact, for papers by Guobin Song Breakdown of academic impact, for papers by Panagiotis Tsapogas Breakdown of academic impact, for papers by Tiffany A. Coon Breakdown of academic impact, for papers by Junfang Deng Breakdown of academic impact, for papers by Loredana Albonici Breakdown of academic impact, for papers by Huan Zhou
Rankless by CCL
2026